↓ Skip to main content

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Overview of attention for article published in New England Journal of Medicine, September 2021

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
51 news outlets
blogs
2 blogs
policy
1 policy source
twitter
132 X users
patent
1 patent
facebook
2 Facebook pages
reddit
4 Redditors
guideline
12 clinical guideline sources
podcasts
2 podcasts

Readers on

mendeley
638 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 132 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 638 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 638 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 60 9%
Other 42 7%
Student > Postgraduate 37 6%
Student > Master 32 5%
Student > Bachelor 30 5%
Other 77 12%
Unknown 360 56%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 155 24%
Biochemistry, Genetics and Molecular Biology 32 5%
Pharmacology, Toxicology and Pharmaceutical Science 19 3%
Agricultural and Biological Sciences 16 3%
Immunology and Microbiology 10 2%
Other 38 6%
Unknown 368 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 515. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2026.
All research outputs
#62,797
of 34,492,055 outputs
Outputs from New England Journal of Medicine
#1,937
of 38,491 outputs
Outputs of similar age
#1,647
of 466,610 outputs
Outputs of similar age from New England Journal of Medicine
#63
of 273 outputs
Altmetric has tracked 34,492,055 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,491 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 466,610 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.